EP 3265553 A1 20180110 - LISTERIA-BASED COMPOSITIONS COMPRISING A PEPTIDE MINIGENE EXPRESSION SYSTEM AND METHODS OF USE THEREOF
Title (en)
LISTERIA-BASED COMPOSITIONS COMPRISING A PEPTIDE MINIGENE EXPRESSION SYSTEM AND METHODS OF USE THEREOF
Title (de)
ZUSAMMENSETZUNGEN AUF BASIS VON LISTERIEN MIT EINEM PEPTIDMINIGENEXPRESSIONSSYSTEM UND VERFAHREN ZUR VERWENDUNG DAVON
Title (fr)
COMPOSITIONS À BASE DE LISTERIA COMPRENANT UN SYSTÈME D'EXPRESSION DE MINIGÈNES CODANT POUR DES PEPTIDES, ET LEURS PROCÉDÉS D'UTILISATION
Publication
Application
Priority
- US 201562127614 P 20150303
- US 2016020571 W 20160303
Abstract (en)
[origin: WO2016141121A1] This disclosure provides compositions, including Listeria delivery vectors comprising minigene expression constructs, and methods of using the same for inducing an immune response against an antigen-expressing tumor and for treating the same, and vaccinating against the same in subjects bearing the tumors.
IPC 8 full level
C12N 1/21 (2006.01); A61K 35/74 (2015.01); A61P 35/00 (2006.01); C07K 14/195 (2006.01); C12N 9/10 (2006.01); C12N 9/90 (2006.01); C12N 15/74 (2006.01)
CPC (source: CN EP IL KR US)
A61K 35/74 (2013.01 - CN EP IL KR US); A61K 38/00 (2013.01 - IL); A61K 39/001106 (2018.08 - CN EP IL KR US); A61K 39/12 (2013.01 - IL); A61K 48/00 (2013.01 - KR); A61K 48/005 (2013.01 - CN); A61P 35/00 (2018.01 - EP IL US); C07K 14/00 (2013.01 - EP IL KR US); C07K 14/195 (2013.01 - CN IL US); C07K 14/82 (2013.01 - IL US); C12N 9/10 (2013.01 - CN); C12N 9/90 (2013.01 - CN); C12N 15/74 (2013.01 - CN EP IL KR US); C12P 21/02 (2013.01 - EP IL KR US); A61K 38/00 (2013.01 - EP KR US); A61K 39/12 (2013.01 - EP US); A61K 2039/522 (2013.01 - EP IL US); A61K 2039/523 (2013.01 - EP IL US); A61K 2039/572 (2013.01 - EP IL US); A61K 2039/585 (2013.01 - EP IL US); C07K 2319/02 (2013.01 - IL US); C07K 2319/036 (2013.01 - EP IL KR US); C12N 2710/20034 (2013.01 - EP IL US); C12N 2710/20071 (2013.01 - EP IL US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2016141121 A1 20160909; AU 2016226247 A1 20170921; AU 2016226247 B2 20211118; AU 2022200643 A1 20220224; AU 2022200643 B2 20220602; CA 2978082 A1 20160909; CN 107406822 A 20171128; EP 3265553 A1 20180110; EP 3265553 A4 20181107; HK 1248758 A1 20181019; IL 254178 A0 20171031; IL 254178 B 20220301; IL 290248 A 20220401; IL 290248 B1 20231201; IL 290248 B2 20240401; JP 2018508212 A 20180329; JP 2021176322 A 20211111; JP 6921750 B2 20210818; JP 7346501 B2 20230919; KR 20170120119 A 20171030; MA 41644 A 20180109; MX 2017011246 A 20180112; SG 10201908086S A 20191030; SG 11201706969Y A 20170928; TW 201704464 A 20170201; TW 202202613 A 20220116; TW I728968 B 20210601; TW I808415 B 20230711; US 10900044 B2 20210126; US 11702664 B2 20230718; US 2019002891 A1 20190103; US 2021246457 A1 20210812; US 2023357781 A1 20231109
DOCDB simple family (application)
US 2016020571 W 20160303; AU 2016226247 A 20160303; AU 2022200643 A 20220201; CA 2978082 A 20160303; CN 201680013085 A 20160303; EP 16759454 A 20160303; HK 18108281 A 20180627; IL 25417817 A 20170828; IL 29024822 A 20220131; JP 2017545631 A 20160303; JP 2021123032 A 20210728; KR 20177024227 A 20160303; MA 41644 A 20160302; MX 2017011246 A 20160303; SG 10201908086S A 20160303; SG 11201706969Y A 20160303; TW 105106585 A 20160303; TW 110116020 A 20160303; US 201615553507 A 20160303; US 202017127530 A 20201218; US 202318316539 A 20230512